This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

New National Survey Shows Majority Of Americans Confident About Choosing Health Coverage

The survey also examined Americans' attitudes toward prescription-drug plan preferences, revealing that consumers are amenable to their pharmacy coverage mirroring the medical benefit when it comes to deductibles.

The majority of those surveyed and particularly the long-term uninsured are willing to pay a $100 deductible for prescription drugs; while deductibles are common for medical insurance, they are not commonplace within drug benefit plans.

The poll also found that many consumers are open to an in-network and out-of-network pharmacy system similar to the network-based approach used in medical care that would require higher copayments for medications purchased at pharmacies that are not part of the plan's preferred network.

"The pharmacy benefit is the most frequently used healthcare benefit, so it is important to understand consumer preferences. This survey shows a definite shift in consumers' mindset around their prescription-drug benefit," Huppert said.  "No matter what their current insurance status, most people surveyed appear willing to accept a drug plan that utilizes cost-saving strategies that are commonplace within medical insurance. This type of information may assist health plans, which will be competing in the public exchanges, in developing their pharmacy benefit strategy heading into 2014."



Additional insights include:

  • The long-term uninsured (more than one year) displayed more price sensitivity to plan premiums than drug copayments and showed a willingness to accept a plan with more restrictions than those currently insured.
  • As subsidies neutralize premiums, factors such as pharmacy network, formulary and copayment amounts can influence plan choice more heavily.

Survey DetailsThe study was conducted by Deft Research LLC on behalf of Express Scripts in November 2012. The national sample included 2,765 adults ages 18 to 64; 39 percent were uninsured, 25 percent were direct payers who currently purchase their own insurance and 36 percent were covered under an employer's insurance plan.

Managing Prescription Drugs in the Exchanges Express Scripts is applying a unique new platform, Health Decision Science SM, to a suite of solutions that can help health plans and their public-exchange consumers better manage clinical and financial outcomes.

Express Scripts' comprehensive offering focuses on the three core capabilities — behavioral sciences, clinical specialization and actionable data — that help drive better decisions and healthier outcomes.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,071.22 -41.93 -0.24%
S&P 500 1,977.80 -5.05 -0.25%
NASDAQ 4,505.8520 -6.3420 -0.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs